Skip to main content
Caplight Logo









Combioxin SA

Combioxin SA

Private
EpalingesHealthcare & Life Scienceshttps://www.combioxin.com/

Last Round

Grant

Jun 11, 2026

Total Funding Raised

$10.1M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Combioxin SA is a biotechnology company that develops novel antitoxin agents for the treatment of severe infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyanti-virulence therapyliposomal drugtoxin trapnon-antibiotic therapyimmunomodulatory treatmentsevere bacterial infectionintensive careantimicrobial resistanceAMRdrug licensingclinical-stage biotechnon-antibioticpharma pipelinesuperbug treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Combioxin SA Comparables

Compare Combioxin SA with similar companies based on industry and business-model similarity.

Combioxin SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Matisse Pharmaceuticals
86%
Adrenomed AG
81%
Infex Therapeutics
78%

Combioxin SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 11, 2026
Corporate FundingAug 25, 2021
SeedNov 28, 2016

Combioxin SA Investors

Notable investors and investment history

Combioxin SA investors
InvestorRounds
Foundation for Technological InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 11, 2026

    $1.37M grant from the State Secretariat for Economic Affairs.

  • May 3, 2025

    Monthly visitors increased 268% MoM.

Combioxin SA Filings

Explore SEC and related filing metadata, where available.

Combioxin SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Combioxin SA's valuation, stock price, and market status.

Is Combioxin SA a public or private company?

Combioxin SA is a private company.

What is the current stock price of Combioxin SA?

Combioxin SA is a private company with no public stock price. Caplight tracks Combioxin SA's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Combioxin SA worth (valuation)?

Valuation information for Combioxin SA is not publicly available.

Can I buy Combioxin SA stock?

Combioxin SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Combioxin SA's last funding round?

Combioxin SA's most recent funding round was Grant on June 11, 2026.

Who are the main investors in Combioxin SA?

Key investors in Combioxin SA include Foundation for Technological Innovation.

Will Combioxin SA IPO soon?

No public IPO plans have been announced for Combioxin SA.

How can I track Combioxin SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Combioxin SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range3
Year Founded2015
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?